|
Volumn 30, Issue 4, 1998, Pages 1427-1429
|
Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
GANCICLOVIR;
METHYLPREDNISOLONE;
PREDNISOLONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER BIOPSY;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
OPPORTUNISTIC INFECTION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT OUTCOME;
ADULT;
ANTILYMPHOCYTE SERUM;
CYCLOSPORINE;
CYTOMEGALOVIRUS INFECTIONS;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HEPATITIS B;
HEPATITIS C;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
LIVER CIRRHOSIS;
LIVER NEOPLASMS;
LIVER TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISORDERS;
METHYLPREDNISOLONE;
MONITORING, IMMUNOLOGIC;
NEOPLASMS, SECOND PRIMARY;
OPPORTUNISTIC INFECTIONS;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
|
EID: 0031832246
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00301-7 Document Type: Conference Paper |
Times cited : (4)
|
References (11)
|